Showing results (1-10 of 762) with videos related to
Sort By:
Pageof 77
Clinical Science (London, England : 1979)|March 1, 1985
Amyloid 'degrading factor activity': a non-specific calcium-mediated effectD L Scott, P Bracken, P A Bacon, et al.Rheumatology International|January 1, 1985
Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugsD L Scott, P A BaconClinical and Experimental Immunology|June 1, 1983
Comparative studies of the high molecular weight amyloid fibril proteins and similar components from normal tissuesD L Scott, G Marhaug, G HusbyScandinavian Journal of Rheumatology. Supplement|January 1, 1987
Long term experience of salazopyrin EN in rheumatoid arthritis (RA)M Farr, P A Bacon, J Coppock, et al.Rheumatology International|January 1, 1984
The significance of IgM antinuclear antinuclear antibody in rheumatoid arthritis and other connective tissue diseasesM C Chellingworth, M Salmon, D L Scott, et al.Annals of the Rheumatic Diseases|October 1, 1983
Musculoskeletal disorders in patients with hyperlipidaemiaG R Struthers, D L Scott, P A Bacon, et al.British Journal of Rheumatology|February 1, 1985
Methods of X-ray assessment in rheumatoid arthritis: a re-evaluationD L Scott, B L Coulton, P A Bacon, et al.British Journal of Rheumatology|November 1, 1983
Partial finger loss: an indicator of severe connective tissue disease with overlap featuresG R Struthers, D L Scott, D G Scott, et al.Clinical Rheumatology|March 1, 1985
Joint sepsis as a complication of sero-negative arthritisC S Barker, D P Symmons, D L Scott, et al.British Journal of Rheumatology|May 1, 1985
Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugsK A Grindulis, D L Scott, M W Robinson, et al.Pageof 77